BluePeak™ metabolic maps: a non-invasive RPE health check
Geographic Atrophy
BluePeak imaging utilizes blue laser light technology to provide a fast, non-invasive and quantitative map of the metabolic activity of the RPE. The BluePeak images show areas of geographic atrophy or other dystrophy of the RPE and disrupted RPE metabolism. Clinicians can now get a functional indicator of retinal health and combine it with structural information from SD-OCT.
The picture created by lipofuscin
Reading the lipofuscin map
A normal part of RPE function is digesting waste products generated by photoreceptors. Lipofuscin, one of the metabolites in this process, accumulates naturally with age in RPE cells. In certain pathologies, over-accumulation of lipofuscin can lead to cellular toxicity and eventually cell death.

Lipofuscin is also a natural fluorophore that glows when exposed to a peak wavelength of blue light (488 nm). BluePeak imaging captures the amount of lipofuscin fluorescence emitted from the retina, creating a metabolic map based on the presence or absence of lipofuscin.
In a healthy eye, there is an even distribution of lipofuscin throughout the retina that forms a characteristic pattern around the fovea (Figure 1). When an RPE cell dies, it can no longer process or store lipofuscin; these areas of atrophy appear as dark regions in BluePeak images (Figure 2). When RPE cells have an abnormally high concentration of lipofuscin they fluoresce and appear as white areas in BluePeak maps (Figure 2); recent work by Prof. Frank Holz, (University of Bonn, Germany) and others indicate that this excess of lipofuscin may indicate cellular malfunction and may be predictive of future atrophy.
Healthy Eye
Figure 1
Figure 2
<   1   2   3   4   >